Search

everythinglearnresearchcommunity

for

Search:↓

Quercetin may help with PCOS symptoms, but more research is needed.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Menopause affects hair and skin; more research needed for treatment.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.